TG Therapeutics
TGTX
#2248
Rank
NZ$15.06 B
Marketcap
NZ$98.45
Share price
0.96%
Change (1 day)
64.41%
Change (1 year)

Earnings for TG Therapeutics (TGTX)

Earnings in 2026 (TTM): NZ$0.24 Billion

According to TG Therapeutics's latest financial reports the company's current earnings are NZ$0.79 Billion. In 2025 the company made an earning of NZ$0.24 Billion, an increase over its 2024 earnings that were of NZ$89.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for TG Therapeutics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.24 B0.29%
2025 NZ$0.24 B169.57%
2024 NZ$89.27 M93.76%
2023 NZ$46.07 M-113.65%
2022 -NZ$0.34 Billion-45.06%
2021 -NZ$0.62 Billion25.42%
2020 -NZ$0.49 Billion62.93%
2019 -NZ$0.31 Billion-3.34%
2018 -NZ$0.32 Billion46.05%
2017 -NZ$0.22 Billion48.38%
2016 -NZ$0.15 Billion29.09%
2015 -NZ$0.12 Billion12.99%
2014 -NZ$98.43 Million180.92%
2013 -NZ$35.04 Million
2009 -NZ$3.18 Million-59.85%
2008 -NZ$7.92 Million
2006 -NZ$17.95 Million-48.34%
2005 -NZ$34.74 Million215.12%
2004 -NZ$11.03 Million29.1%
2003 -NZ$8.54 Million159.59%
2002 -NZ$3.29 Million
2000 -NZ$5.65 Million12.38%
1999 -NZ$5.03 Million7.69%
1998 -NZ$4.67 Million-49.02%
1997 -NZ$9.16 Million82.14%
1996 -NZ$5.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
NZ$0.42 B 70.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Dr. Reddy's Laboratories
RDY
NZ$0.90 B 261.82%๐Ÿ‡ฎ๐Ÿ‡ณ India